Literature DB >> 22114366

A Synthesis of the Tricyclic Core Structure of FR901483 Featuring an Ugi Four-Component Coupling and a Remarkably Selective Elimination Reaction.

Hirofumi Seike1, Erik J Sorensen.   

Abstract

Three key reactions, an efficient Ugi four-component coupling, a regiospecific, base-mediated elimination reaction, and an intramolecular nitrone/alkene [3+2] cycloaddition, were used to achieve an effective synthesis of the tricyclic molecular framework of the immunosuppressant FR901483. The outcome of a control experiment supports the idea that an internal deprotonation by an alkoxide ion is the origin of the site selectivity observed in the base-induced elimination of hydroxy mesylate 17.

Entities:  

Year:  2008        PMID: 22114366      PMCID: PMC3221389          DOI: 10.1055/s-2008-1042813

Source DB:  PubMed          Journal:  Synlett        ISSN: 0936-5214            Impact factor:   2.454


  20 in total

1.  Total synthesis of FR901483.

Authors:  M Ousmer; N A Braun; M A Ciufolini
Journal:  Org Lett       Date:  2001-03-08       Impact factor: 6.005

2.  A formal total synthesis of (-)-FR901483, using a tandem cationic aza-Cope rearrangement/Mannich cyclization approach.

Authors:  Kay M Brummond; Sang-phyo Hong
Journal:  J Org Chem       Date:  2005-02-04       Impact factor: 4.354

3.  Addition of iodine isocyanate to olefins. Scope and synthetic utility.

Authors:  A Hassner; M E Lorber; C Heathcock
Journal:  J Org Chem       Date:  1967-03       Impact factor: 4.354

4.  Efficient approach to the Azaspirane core of FR 901483.

Authors:  Silvia Kaden; Hans-Ulrich Reissig
Journal:  Org Lett       Date:  2006-10-12       Impact factor: 6.005

5.  Synthetic studies toward (-)-FR901483 using a conjugate allylation to install the C-1 quaternary carbon.

Authors:  Dimitar B Gotchev; Daniel L Comins
Journal:  J Org Chem       Date:  2006-12-08       Impact factor: 4.354

6.  Nucleophilic Alkylation on Anti-Bredt Iminium Ions. Facile Entry to the Synthesis of 1-Alkylated 2-Azabicyclo[3.3.1]nonanes (Morphans) and 5-Azatricyclo[6.3.1.0(1,5)]dodecane.

Authors:  Naoki Yamazaki; Hidetaka Suzuki; Chihiro Kibayashi
Journal:  J Org Chem       Date:  1997-11-28       Impact factor: 4.354

7.  Unusual cyclopropanation of 9-bromocamphor derivatives: a novel formal C(1)-C(7) bond cleavage of camphor.

Authors:  Wei-Dong Z Li; Yu-Rong Yang
Journal:  Org Lett       Date:  2005-07-07       Impact factor: 6.005

8.  Radical carboazidation: expedient assembly of the core structure of various alkaloid families.

Authors:  Philippe Panchaud; Cyril Ollivier; Philippe Renaud; Sarunas Zigmantas
Journal:  J Org Chem       Date:  2004-04-16       Impact factor: 4.354

9.  Stereocontrolled total synthesis of potent immunosuppressant FR901483.

Authors:  Toshiyuki Kan; Teppei Fujimoto; Shigeru Ieda; Yusuke Asoh; Haruka Kitaoka; Tohru Fukuyama
Journal:  Org Lett       Date:  2004-08-05       Impact factor: 6.005

10.  FR901483, a novel immunosuppressant isolated from Cladobotryum sp. No. 11231. Taxonomy of the producing organism, fermentation, isolation, physico-chemical properties and biological activities.

Authors:  K Sakamoto; E Tsujii; F Abe; T Nakanishi; M Yamashita; N Shigematsu; S Izumi; M Okuhara
Journal:  J Antibiot (Tokyo)       Date:  1996-01       Impact factor: 2.649

View more
  3 in total

1.  Synthetic studies toward lapidilectine-type Kopsia alkaloids.

Authors:  Erica E Schultz; Brian G Pujanauski; Richmond Sarpong
Journal:  Org Lett       Date:  2012-01-03       Impact factor: 6.005

2.  Enantioselective Synthesis of the Tricyclic Core of FR901483 Featuring a Rh-Catalyzed [2+2+2] Cycloaddition.

Authors:  Stéphane Perreault; Tomislav Rovis
Journal:  Synthesis (Stuttg)       Date:  2013       Impact factor: 3.157

3.  Biosynthesis of the Immunosuppressant (-)-FR901483.

Authors:  Zhuan Zhang; Yui Tamura; Mancheng Tang; Tianzhang Qiao; Michio Sato; Yoshihiro Otsu; Satoshi Sasamura; Masatoshi Taniguchi; Kenji Watanabe; Yi Tang
Journal:  J Am Chem Soc       Date:  2020-12-29       Impact factor: 15.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.